StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SFQ.DE$20.25-0.24%
Fair $20.25+0.0%

SFQ.DE

SAF-Holland SE

Consumer Cyclical / Auto PartsXETRA

$20.25

-0.05 (-0.24%)

Fairly Valued+0.0%Fair Value $20.25Fund rank 31/100 · Data gapFallback financials|
SA 54/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $141.0M · quality 57.0/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 68/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

54/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · SFQ.DELocal privado en este navegador · SAF-Holland SE
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$919M

P/E

18.1x

↑

EV/EBITDA

5.6x

↓

ROE

14.8%

↑

Gross Margin

22.3%

↓

Debt/Equity

1.48

↑
52-Week Range$20
$13$21

TradingView lightweight chart

SFQ.DE price, volumen y niveles de valoración

Último $20.85Periodo +8.3%
Fair value: $20.25

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

+14.6%

FCF CAGR

+112.2%

FCF margin

7.6%

FCF / Net income

1.85x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.88B · net income $77.3M · FCF $143.2M

2021-FY → 2024-FY

Gross margin

22.3%+5.5% pts

Operating margin

8.8%+2.7% pts

Net margin

4.1%+1.2% pts

FCF margin

7.6%+6.4% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$1.88B$1.88B$2.11B$1.57B$1.25B
Net Income$77.3M$77.3M$79.9M$61.1M$36.7M
EBITDA$248.3M$248.3M$234.8M$149.3M$115.8M
EPS1.701.701.761.35—
Gross Margin22.3%22.3%19.6%16.6%16.8%
Operating Margin8.8%8.8%8.2%7.1%6.0%
Net Margin4.1%4.1%3.8%3.9%2.9%
Balance Sheet
Debt/Equity1.481.481.491.751.01
Current Ratio2.302.30———
Cash Flow
Free Cash Flow$143.2M$143.2M$141.0M$117.1M$15.0M
Returns
ROE14.8%14.8%16.9%13.9%9.9%
Valuation
P/E18.0818.088.326.87—
EV/EBITDA5.615.614.796.356.90
P/B1.761.761.410.961.60
Growth & Yield
Revenue Growth-10.9%-10.9%34.6%25.6%—
EPS Growth-3.4%-3.4%30.4%——
Dividend Yield3.1%3.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

1.9%

fácil

EPS terminal req.

$1.80

Spread vs growth

-5.3%

5Y implied EPS CAGR

5.0%

razonable

EPS terminal req.

$2.17

Spread vs growth

-8.5%

10Y implied EPS CAGR

7.5%

razonable

EPS terminal req.

$3.50

Spread vs growth

-10.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +32.3%

Total return

+32.3%

Start / end P/E

9.2x → 12.3x

EPS bridge

1.76 → 1.70

Residual

-1.2%

EPS growth-3.4%
Multiple rerating+33.7%
Dividend+3.1%
Residual / FX / buybacks / cross-term-1.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.